HIGHLIGHTS   |  February 8, 2020   Refinement of Surgical Treatment of Cancer Named Advance of the Year ASCO named the advance in their annual report, Clinical Cancer Advances: ASCO’s Annual Report on Progress Against Cancer, highlighting novel advances and listing research priorities for the cancer community. Read more   Variability in Information Content on Lung Cancer Screening Websites Inconsistencies observed by researchers on these websites indicated that efforts are needed to improve website content and readability. Read more   In Case You Missed It   Top-Line Data Reported for Pralsetinib in Patients with RET Fusion-Positive NSCLC Independent centrally reviewed top-line data for pralsetinib in patients with RET fusion-positive non-small cell lung cancer (NSCLC) was announced by Blueprint Medicines, the developer of the agent. Read more